Literature DB >> 21337604

Infantile muscular dystrophy in Canadian aboriginals is an αB-crystallinopathy.

Marc R Del Bigio1, Albert E Chudley, Harvey B Sarnat, Craig Campbell, Sharan Goobie, Bernard N Chodirker, Duygu Selcen.   

Abstract

OBJECTIVE: A recessively transmitted fatal hypertonic infantile muscular dystrophy has been described in Canadian aboriginals. The affected infants present with progressive limb and axial muscle stiffness and develop severe respiratory insufficiency, and most die in the first year of life. We sought to determine the genetic basis of this disease.
METHODS: We performed histochemical, immunocytochemical, electron microscopy, and molecular genetic studies in a cohort of 12 patients affected by this disease.
RESULTS: Conventional histochemical and electron microscopy studies suggested myofibrillar myopathy (MFM). Therefore, we searched for ectopic expression of multiple proteins typical of MFM. Alpha B-crystallin (αBC) expression was absent from all fibers using a monoclonal antibody raised against the entire protein. However, a monoclonal antibody directed against the first 10 residues of αBC immunostained portions of abnormal fibers. Pursuing this clue, we searched for mutations in the gene for αBC (CRYAB) in available DNA samples of 8 patients. All harbored a homozygous deletion, c.60C, predicting a Ser to Ala change at codon 21 and a stop codon after 23 missense residues (p.Ser21AlafsX24). Clinically unaffected parents were heterozygous for this mutation.
INTERPRETATION: The homozygous c.60delC in CRYAB pinpoints the genetic basis of the fatal infantile hypertonic muscular dystrophy of Canadian aboriginals. MFMs are typically transmitted by dominant inheritance, but in this disease the parental phenotype is rescued by limited expression of the highly truncated nonfunctional mutant gene product. The severe patient phenotype is due to homozygosity for the markedly hypomorphic allele. Ann Neurol, 2011.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21337604      PMCID: PMC3085857          DOI: 10.1002/ana.22331

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

1.  Alpha-crystallin-incorporated collagen matrices as an aid for dermal wound healing.

Authors:  M Rafiuddin Ahmed; D Gopinath; K Gomathi; P K Sehgal; R Jayakumar
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2004-05-15       Impact factor: 3.368

2.  Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments.

Authors:  F Bennardini; A Wrzosek; M Chiesi
Journal:  Circ Res       Date:  1992-08       Impact factor: 17.367

3.  Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins.

Authors:  J L De Bleecker; A G Engel; B B Ertl
Journal:  J Neuropathol Exp Neurol       Date:  1996-05       Impact factor: 3.685

4.  Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases.

Authors:  S Nakano; A G Engel; A J Waclawik; A M Emslie-Smith; N A Busis
Journal:  J Neuropathol Exp Neurol       Date:  1996-05       Impact factor: 3.685

5.  Autosomal recessive, fatal infantile hypertonic muscular dystrophy among Canadian Natives.

Authors:  A G Lacson; S S Seshia; H B Sarnat; J Anderson; W R DeGroot; A Chudley; C Adams; H Z Darwish; R B Lowry; S Kuhn
Journal:  Can J Neurol Sci       Date:  1994-08       Impact factor: 2.104

6.  A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy.

Authors:  P Vicart; A Caron; P Guicheney; Z Li; M C Prévost; A Faure; D Chateau; F Chapon; F Tomé; J M Dupret; D Paulin; M Fardeau
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

7.  Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations.

Authors:  Duygu Selcen; Andrew G Engel
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

8.  Mutations in myotilin cause myofibrillar myopathy.

Authors:  Duygu Selcen; Andrew G Engel
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

9.  Missense mutations in desmin associated with familial cardiac and skeletal myopathy.

Authors:  L G Goldfarb; K Y Park; L Cervenáková; S Gorokhova; H S Lee; O Vasconcelos; J W Nagle; C Semino-Mora; K Sivakumar; M C Dalakas
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

10.  Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.

Authors:  Duygu Selcen; Kinji Ohno; Andrew G Engel
Journal:  Brain       Date:  2004-01-07       Impact factor: 13.501

View more
  21 in total

Review 1.  Myofibrillar myopathies: new developments.

Authors:  Montse Olivé; Rudolf A Kley; Lev G Goldfarb
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

Review 2.  Small heat-shock proteins: important players in regulating cellular proteostasis.

Authors:  Teresa M Treweek; Sarah Meehan; Heath Ecroyd; John A Carver
Journal:  Cell Mol Life Sci       Date:  2014-10-29       Impact factor: 9.261

Review 3.  The BAG3-dependent and -independent roles of cardiac small heat shock proteins.

Authors:  Xi Fang; Julius Bogomolovas; Christa Trexler; Ju Chen
Journal:  JCI Insight       Date:  2019-02-21

Review 4.  Neuropathy- and myopathy-associated mutations in human small heat shock proteins: Characteristics and evolutionary history of the mutation sites.

Authors:  Rainer Benndorf; Jody L Martin; Sergei L Kosakovsky Pond; Joel O Wertheim
Journal:  Mutat Res Rev Mutat Res       Date:  2014-03-06       Impact factor: 5.657

Review 5.  Small heat shock proteins in redox metabolism: implications for cardiovascular diseases.

Authors:  Elisabeth S Christians; Takahiro Ishiwata; Ivor J Benjamin
Journal:  Int J Biochem Cell Biol       Date:  2012-06-15       Impact factor: 5.085

Review 6.  Myofibrillar myopathies.

Authors:  Duygu Selcen
Journal:  Neuromuscul Disord       Date:  2011-01-20       Impact factor: 4.296

7.  Alexander disease.

Authors:  Albee Messing; Michael Brenner; Mel B Feany; Maiken Nedergaard; James E Goldman
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

8.  Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.

Authors:  Duygu Selcen; Mark B Bromberg; Steven S Chin; Andrew G Engel
Journal:  Neurology       Date:  2011-11-16       Impact factor: 9.910

Review 9.  Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Sabita Kawan; Bjarne Udd
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

Review 10.  The role of αB-crystallin in skeletal and cardiac muscle tissues.

Authors:  Ivan Dimauro; Ambra Antonioni; Neri Mercatelli; Daniela Caporossi
Journal:  Cell Stress Chaperones       Date:  2017-11-30       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.